<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02334059</url>
  </required_header>
  <id_info>
    <org_study_id>STUDY00001623</org_study_id>
    <nct_id>NCT02334059</nct_id>
  </id_info>
  <brief_title>Effect of Single Dose Ketamine and Magnesium on Postoperative Pain in Patients Undergoing Bariatric Surgery</brief_title>
  <official_title>Effect of Single Dose Ketamine and Magnesium on Postoperative Pain in Patients Undergoing Bariatric Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Milton S. Hershey Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Milton S. Hershey Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Opioid sparing anesthesia is extremely important in the post-operative obese population. With
      more and more obese patients entering the operating room a multi-modal approach to analgesia
      is crucial. Finding effective alternatives to opioid therapy is the rationale of this
      proposal. Literature involving ketamine and magnesium in bariatric surgical patients is very
      sparse.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      1. Patient will be identified by surgeon and consented by member of the research team

        2. Patient will be randomized to one of three groups on the day of surgery

        3. Following securement of the endotracheal tube, the study medication will be administered
           over 10 minutes via an IV infusion pump.

        4. The subject will receive ketamine, ketamine plus magnesium or a placebo.

        5. Following surgery, the patient will be taken to the post anesthesia care unit (PACU) and
           set up with standard ASA monitoring as well as end-tidal CO2 via nasal cannula. A
           hydromorphone patient controlled analgesia (PCA) pump will be set-up by nursing and
           given to the patient. Standard dosing of 0.2 mg bolus, every 6 minutes with a maximum 2
           mg will be the starting dose as is standard for these patients post-operatively.

        6. Primary outcome will be the total amount of hydromorphone used in the first 24 hours
           post-operatively.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">November 2015</start_date>
  <completion_date type="Anticipated">November 2019</completion_date>
  <primary_completion_date type="Anticipated">July 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Total Hydromorphone use</measure>
    <time_frame>1st 24 hours post-op</time_frame>
    <description>Total hydromorphone use in 1st 24 hours post-operatively.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain Scores using Visual Analogue Scale (VAS)</measure>
    <time_frame>1st 24 hours post-op</time_frame>
    <description>Pain scores using VAS scale will be recorded pre-operatively, in the PACU, and every 4 hours until 24 hours post-op</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sedation scores using Ramsey Sedation Scale</measure>
    <time_frame>1st 24 hours post-op</time_frame>
    <description>Sedation will be measure using a Ramsey sedation scale upon arrival to the PACU and every 4 hours until 24 hours post-op</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nausea Scores using Likert Scale</measure>
    <time_frame>1st 24 hours post-op</time_frame>
    <description>Nausea scores will be taken using a Likert scale: none, mild, moderate, severe. Scored at arrival to PACU and every 4 hours after until 24 hours post-op</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intraoperative fentanyl use</measure>
    <time_frame>Intraoperative period</time_frame>
    <description>Total amount of fentanyl used by the anesthetic provider in the operating room will be recorded.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intraoperative minimum alveolar concentration (MAC) of desflurane</measure>
    <time_frame>Intraoperative period</time_frame>
    <description>The average MAC concentration of desflurane will be recorded during the intraoperative period</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">108</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>Ketamine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ketamine: 0.5 mg/kg IV dose</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ketamine plus magnesium</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ketamine plus magnesium group: 0.5 mg/kg IV dose as well as Magnesium 2 grams IV</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo (normal saline)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ketamine</intervention_name>
    <description>Ketamine infusion plus placebo infusion of normal saline</description>
    <arm_group_label>Ketamine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ketamine plus magnesium</intervention_name>
    <description>Ketamine plus magnesium infusion</description>
    <arm_group_label>Ketamine plus magnesium</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>2 placebo infusions</description>
    <arm_group_label>Ketamine</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>Normal Saline</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Subjects undergoing laparoscopic sleeve gastrectomy

          2. Consenting adults age 18-80

          3. ASA II to ASA III

          4. Ability to understand and use a PCA

          5. Required to be hospitalized for at least 24 hours post-op

        Exclusion Criteria:

          1. Patient refusal

          2. Chronic opiate use (daily opiate use for &gt;3 months)

          3. Chronic Kidney disease (Creatinine&gt;2)

          4. Known allergy or adverse effect of ketamine, magnesium or hydromorphone

          5. Patients with documented psychiatry (Maniac or MDP) history

          6. Patient unable to give informed consent

          7. Patient with limited or no English fluency
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sanjib Adhikary, MB, BS,MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>PSHMC College of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Milton S.Hershey Medical Center</name>
      <address>
        <city>Hershey</city>
        <state>Pennsylvania</state>
        <zip>17033</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 23, 2014</study_first_submitted>
  <study_first_submitted_qc>January 5, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 8, 2015</study_first_posted>
  <last_update_submitted>March 1, 2018</last_update_submitted>
  <last_update_submitted_qc>March 1, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 2, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Milton S. Hershey Medical Center</investigator_affiliation>
    <investigator_full_name>Sanjib Adhikary</investigator_full_name>
    <investigator_title>Associate professor, Department of Anesthesiology,</investigator_title>
  </responsible_party>
  <keyword>opioid sparing</keyword>
  <keyword>ketamine</keyword>
  <keyword>obese</keyword>
  <keyword>magnesium</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ketamine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

